Product Information
OLANZAPINE 10 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.1090 per EA under NDC 00904637661. Its NADAC has been published 610 times since Jan 28, 2015.
FDA first approved this application on Apr 23, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904637661
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OLANZAPINEApproval Type
Generic (ANDA)
FDA Application
ANDA076255FDA Approved
4/23/2012
TE Code
AB
On Market Since
4/23/2012
Pharmacological Classes
Price Statistics
The NADAC for OLANZAPINE 10 MG TABLET has been published 610 times since Jan 28, 2015, and over the history we have for it it has declined 52.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1090 per EA |
|---|---|
| All-time high | $0.2593 (Aug 12, 2015) |
| All-time low | $0.0926 (Nov 20, 2024) |
| 52-week high | $0.1096 |
| 52-week low | $0.1060 |
| Median price | $0.1448 |
| Average price | $0.1488 |
| Largest weekly change | +21.7% (Jul 21, 2021) |
| Weeks tracked | 610 |
| Tracking since | Jan 28, 2015 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Olanzapine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OLANZAPINE 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OLANZAPINE 10 MG TABLET, manufactured by Major Pharmaceuticals, is $0.1090 per EA (NDC 00904637661), effective Sep 30, 2026.
How has the price of OLANZAPINE 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for OLANZAPINE 10 MG TABLET has declined 52.1%. It has been tracked across 610 weekly CMS publications since Jan 28, 2015.
What are the highest and lowest recorded NADAC prices for OLANZAPINE 10 MG TABLET?
Since Jan 28, 2015, the NADAC for OLANZAPINE 10 MG TABLET has ranged from a low of $0.0926 (Nov 20, 2024) to a high of $0.2593 (Aug 12, 2015), with a median of $0.1448 per EA.
Are there cheaper alternatives to OLANZAPINE 10 MG TABLET?
Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OLANZAPINE 10 MG TABLET, is $0.1058 per EA — about 3% below OLANZAPINE 10 MG TABLET.
Who manufactures OLANZAPINE 10 MG TABLET?
OLANZAPINE 10 MG TABLET (NDC 00904637661) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.